News

Psychedelic drug MDMA rejected as treatment for PTSD despite veterans’ support

todayAugust 9, 2024 2

share close
Psychedelic drug MDMA rejected as treatment for PTSD despite veterans’ support
The FDA rejected a company’s application to market the party drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder.

​ The FDA rejected a company’s application to market the party drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder. 

Written by:

Rate it

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

0%